Biocon has appointed Shreehas Tambe as Chief Executive Officer and Managing Director, effective April 1, 2026. He will become the first CEO of the integrated Biocon entity, leading a unified platform across biosimilars and generics. The company also announced the appointment of Kedar Upadhye as Chief Financial Officer, strengthening its leadership team during a key … Continue reading Biocon Appoints Shreehas Tambe as CEO & MD